The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest biosimilar growth hormones market share, and Middle East was the fastest-growing region in 2022.

The global biosimilar growth hormones market is expected to grow from $0.64 billion in 2022 to $0.7 billion in 2023 at a compound annual growth rate (CAGR) of 8.4%. The biosimilar growth hormones market is expected to grow from $0.98 billion in 2027 at a CAGR of 8.8%.

Major Driver In The Biosimilar Growth Hormones Market ­– Growth In Number Of Children Suffering From Growth Hormone Deficiency
Damage to the pituitary gland or hypothalamus causes growth hormone insufficiency, which can be the result of an aberrant formation that occurred before the child was born (congenital) or something that happened during or after delivery (acquired). One in every 3,800 newborns is born with a growth hormone deficit. Furthermore, some children develop it later in life as a result of a brain tumour, brain surgery, radiation therapy, injury, or infection. As a result, an increase in the number of children suffering from growth deficits supports market growth.

View More On The Biosimilar Growth Hormones Market Report 2023 – https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report

Key Biosimilar Growth Hormones Market Segments
1) By Route Of Administration: Intravenous, Subcutaneous, Intramuscular, Oral
2) By Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications
3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Speciality Clinics

Recent Biosimilar Growth Hormones Market Trend – Implementing Recombinant DNA Technology
The use of recombinant DNA technology (rDNA technology) to create biosimilar growth hormone is a new trend. For example, rBIO was created in 2020 using recombinant DNA technology. Rubio has the ability to reduce the cost of insulin by 30%, making insulin and other prescriptions more affordable in the United States.

Biosimilar Growth Hormones Market Prominent Players
Major players in the biosimilar growth hormones market are Biopartners and LG Chem, Amega Biotech, Eli Lilly and Company, Genetech Inc., Novartis AG, Zhongshan Hygene Biopharm Co. Ltd., Merck, Sanofi S.A., Biosidus, and Ferring Pharmaceuticals.

Request A Sample Of The Global Biosimilar Growth Hormones Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3391&type=smp

The Biosimilar Growth Hormones Global Market Report 2023  provides a comprehensive overview on the biosimilar growth hormones market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the biosimilar growth hormones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

A peptide hormone that promotes cellular regeneration, cell division, and growth in humans and other animals is referred to as biosimilar growth hormone. As a result, it is critical to the advancement of humanity. It is a mitogen that only affects certain types of cells.

View More Related Reports –
Biosimilars Global Market Report 2023
Biosimilar Monoclonal Antibodies Global Market Report 2023
Biosimilar Lymphocyte Modulator Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model